Univec's bifurcated safety needle gains US nod:
This article was originally published in Clinica
Executive Summary
Univec has received FDA 510(k) clearance to market its bifurcated safety needle, which has been designed to meet the US government's requirements for safe administration of the smallpox vaccine. The Farmingdale, New York company says that its patented needles are the only bifurcated needles available that use a sliding sheath mechanism that complies with the US needle stick legislation and Occupational Safety and Health Administration (OSHA) regulations to effectively reduce the risk of accidental needle sticks.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.